- Home
- GNTA vs SACH Comparison
GNTA vs SACH Comparison
Compare GNTA & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNTA | SACH |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.4M | 52.0M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | GNTA | SACH |
|---|---|---|
| Price | $1.78 | $1.14 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 100.7K | ★ 184.7K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | N/A | ★ 17.70% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,906,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.35 | $0.80 |
| 52 Week High | $10.00 | $1.48 |
Technical Indicators
Market Signals| Indicator | GNTA | SACH |
|---|---|---|
| Relative Strength Index (RSI) | 38.43 | 63.85 |
| Support Level | $1.80 | $1.00 |
| Resistance Level | $2.07 | $1.14 |
| Average True Range (ATR) | 0.22 | 0.05 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 50.59 | 85.00 |
Price Performance
Historical ComparisonAbout GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.